top of page
MATProviders-Magazine-logo

MATPROVIDERS MAGAZINE

Advancing the standards of Medicated Assisted Treatment for opioid use disorder through clinical insights, research, and dedicated healthcare narratives.

LATEST CLINICAL RESEARCH

Monthly Insight

How do you integrate Brixadi into your daily practice for patients with severe OUD?

Share your clinical observations and strategies for transitioning patients to long-acting buprenorphine. Selected insights will be featured in our upcoming clinical pearls column.

Advertising Opportunities

Bridge the gap between therapeutic innovation and clinical practice. Our platform delivers your message directly to healthcare providers specialized in Medicated Assisted Treatment for opioid use disorder.

15K+

MONTHLY UNIQUE PRESCRIBERS

Direct connectivity to high-volume prescribers of Suboxone and Sublocade across top-tier clinical networks.

92%

DECISION MAKER ENGAGEMENT

Our editorial focus on case studies ensures your message reaches attentive practitioners in the MAT field.

100%

CLINICAL PRACTITIONER FOCUS

Zero-waste targeting for manufacturers of Naltrexone and Brixadi. Reach only the prescribers that matter.

SUBOXONE • NALTREXONE • SUBLOCADE • BRIXADI

bottom of page